Tirzepatide (Mounjaro, Zepbound) works as a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
We may update our Privacy Policy from time to time
Internet: (accessed February 25 2025)
Whether youre traveling to take a vacation, for business, or to visit family, youll need to consider how to manage your GLP-1 RA during your travels
While most experts agree that microdosing generally means that someone is taking a smaller dose of a drug than the FDA-approved regimen, there are a few ways that this can happen